These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28577507)

  • 1. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
    Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
    Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
    Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antimycobacterial activity of 3,5-dinitrobenzamide derivatives containing fused ring moieties.
    Wang A; Huang G; Wang B; Lv K; Wang H; Tao Z; Liu M; Guo H; Lu Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2945-2948. PubMed ID: 30006066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial activity of new N(1)-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives.
    Zampieri D; Mamolo MG; Vio L; Romano M; Skoko N; Baralle M; Pau V; De Logu A
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3287-3290. PubMed ID: 27241693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Saxena S; Meda N; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Mar; 24(6):1298-307. PubMed ID: 26867485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro antimicrobial evaluation of novel Imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs.
    Al-Tel TH; Al-Qawasmeh RA; Zaarour R
    Eur J Med Chem; 2011 May; 46(5):1874-81. PubMed ID: 21414694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Antimycobacterial Activity of Novel Imidazo[1,2-a]pyridine Amide-Cinnamamide Hybrids.
    Li L; Li Z; Liu M; Shen W; Wang B; Guo H; Lu Y
    Molecules; 2015 Dec; 21(1):E49. PubMed ID: 26729085
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Antoci V; Cucu D; Zbancioc G; Moldoveanu C; Mangalagiu V; Amariucai-Mantu D; Aricu A; Mangalagiu II
    Future Med Chem; 2020 Feb; 12(3):207-222. PubMed ID: 31916456
    [No Abstract]   [Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2-c]pyridine Mannich bases.
    Jose G; Suresha Kumara TH; Sowmya HBV; Sriram D; Guru Row TN; Hosamani AA; More SS; Janardhan B; Harish BG; Telkar S; Ravikumar YS
    Eur J Med Chem; 2017 May; 131():275-288. PubMed ID: 28340368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
    Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New polyfunctional imidazo[4,5-C]pyridine motifs: synthesis, crystal studies, docking studies and antimicrobial evaluation.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Jasinski JP; Millikan SP; Chandrika N; More SS; Harish BG
    Eur J Med Chem; 2014 Apr; 77():288-97. PubMed ID: 24657565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series.
    Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
    Kang S; Kim RY; Seo MJ; Lee S; Kim YM; Seo M; Seo JJ; Ko Y; Choi I; Jang J; Nam J; Park S; Kang H; Kim HJ; Kim J; Ahn S; Pethe K; Nam K; No Z; Kim J
    J Med Chem; 2014 Jun; 57(12):5293-305. PubMed ID: 24870926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
    Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
    Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.